Blog
- Advocacy Article Types (75)
- AIPLA Direct (35)
- CLE (98)
- Congresses (1)
- Document Type (2)
- Event Types (37)
- Global (37)
- Government Department (48)
- Innovate (54)
- News Types (41)
- Newsstand (535)
Location
Credits
60 Minutes of MCLE
Registration for this session is now closed. Please contact aipla@aipla.org for late registration for this session.
Medical Devices and Cybersecurity and Privacy, Oh My!
Moderator: Frank Gerratana, Fish & Richardson, Boston, MA
Speakers:
Paul S. Rosenblat, Butler Snow, Ridgeland, MS
Melissa Runsten, Debevoise & Plimpton, Washington, DC
Patrick Gallagher, Duane Morris, Boca Raton, FL
Speakers
-
Gallagher, Patrick C.
Duane Morris, LLP | Partner
Patrick C. Gallagher, Ph.D., chairs the Pharmaceuticals and Biopharmaceuticals Litigation and Regulatory group of Duane Morris' global Intellectual Property practice and serves as a team lead for the Life Sciences and Medical Technologies industry group. -
Runsten, Melissa B.
Debevoise & Plimpton, LLP | Associate
Melissa Runsten is a corporate associate and a member of the Healthcare & Life Sciences Group. -
Rosenblatt, Paul S.
Butler Snow, LLP | Attorney
Paul Rosenblatt assists in leading the national expert team in the pelvic mesh litigation and has selected and developed experts, taken and defended expert witness depositions, and prepared experts for trials. -
Gerratana, Frank
Calyx Law LLP | Partner
Frank Gerratana is a high-tech and intellectual property attorney at the intersection of law, business, and emerging technology. With degrees in computer science & electrical engineering, he brings deep technical acumen to his clients’ most complex legal challenges. Frank works with a wide range of organizations—from venture-backed startups to Fortune 500 corporations—helping them develop robust patent strategies, navigate legal hurdles, and mitigate IP-related risks. His forward-looking guidance enables companies to protect and commercialize their innovations, whether they involve artificial intelligence, blockchain, robotics, medical devices, microprocessor architecture, or financial technology.